View Older Stories View More Recent Stories

Mar 8, 2018 07:46AM Collegium Pharma (COLL): Emerging Leader in Opioid Pain Management - HC Wainwright

Mar 8, 2018 07:30AM Trevena (TRVN): Commercial Countdown Begins - HCWainwright

Mar 6, 2018 07:09AM H.C. Wainwright Upgrades Durect Corp (DRRX) to Buy

Feb 15, 2018 08:58AM H.C. Wainwright Remains Bullish on Galmed Pharma (GLMD) Followng Sell Off

Feb 12, 2018 07:19AM Galmed Pharmaceuticals (GLMD) PT Raised to $24 at H.C. Wainwright; 'Imminent Data Catalyst'

Feb 7, 2018 07:08AM Achaogen (AKAO) PT Raised to $31 at H.C. Wainwright

Jan 30, 2018 08:01AM Madrigal Pharma (MDGL) MGL-3196's Is Just About "Validated" For FH - HC Wainwright

Jan 26, 2018 07:41AM Gemphire Therapeutics (GEMP): PT To $28 Ahead of Phase 3 FH Trial - HC Wainwright

Jan 24, 2018 07:43AM CymaBay Therapeutics (CBAY): 3 Catalsyts To Drive Value Creation, PT To $18 - HC Wainwright

Dec 7, 2017 07:18AM Galectin Therapeutics (GALT) PT Raised to $10 at H.C. Wainwright; Market Got it Wrong

Nov 29, 2017 07:31AM UPDATE: H.C. Wainwright Starts Madrigal Pharmaceuticals (MDGL) at Buy

Nov 28, 2017 07:23AM Galectin Therapeutics (GALT): Low Data Hurdle In Early Dec, PT To $6 - HC Wainwright

Nov 6, 2017 07:32AM Tetraphase Pharma (TTPH): Multiple Value-Creating Milestones, PT To $17 - HC Wainwright

Nov 3, 2017 07:53AM Dicerna Pharmaceuticals (DRNA) PT Raised to $10 at H.C. Wainwright on 3Q Report; 'Landmark Deal With BI on NASH Target Validates GalXC Platform'

Nov 3, 2017 07:10AM H.C. Wainwright Downgrades Ocera Therapeutics (OCRX) to Neutral Following Acquisition

Nov 1, 2017 07:51AM Nabriva Therapeutics AG (NBRV) PT Raised to $20 at H.C. Wainwright on 'Model Update Ahead of De-risked LEAP 2 Data in Spring 2018'

Oct 30, 2017 07:15AM Aurinia Pharmaceuticals (AUPH) PT Raised to $12 at H.C. Wainwright; 'R&D Day Showcases New Indications, Expanded Opportunity'

Oct 20, 2017 07:06AM UPDATE: H.C. Wainwright Downgrades Durect Corp (DRRX) to Neutral

Oct 12, 2017 07:34AM Trevena (TRVN): Cutting PT To $7 - HC Wainwright

Sep 11, 2017 07:06AM H.C. Wainwright Starts Collegium Pharmaceutical (COLL) at Buy

Aug 31, 2017 07:05AM UPDATE: H.C. Wainwright Starts Gemphire Therapeutics (GEMP) at Buy

Aug 28, 2017 07:18AM Nabriva (NBRV): Raising PT Ahead Of Expected Positive Ph1 Results For lefamulin - HCWainwright

Aug 8, 2017 07:34AM Galmed Pharma (GLMD): 1H18 Readout Should Validate Aramchol In NASH - HC Wainwright

Jul 24, 2017 08:00AM H.C. Wainwright Analysts Earn Number One Rankings in 2017 Thomson Reuters Analyst Awards

Jul 18, 2017 07:07AM Paratek Pharmaceuticals (PRTK): Raising PT On Another Phase III Success - HC Wainwright

Jul 17, 2017 09:49AM CymaBay Therapeutic (CBAY) PT Raised to $12 at H.C. Wainwright; 'Seladelpar's Phase 2 PBC Results More Robust Than Ocaliva'

Jul 10, 2017 07:49AM Akebia Therapeutics (AKBA): Cutting PT By $1 On Capital Raise Dilution - HC Wainwright

Jul 6, 2017 08:45AM Streetwise Reports Examines How Analysts Take Note as a Small-Cap Biotech Completes Early Enrollment for Phase 3 Trial

Jun 29, 2017 07:44AM Nabriva (NBRV): Investor Meeting Takeaways - HC Wainwright

Jun 23, 2017 07:25AM DURECT Corp (DRRX): Positive Signs For Posimir - HC Wainwright

Jun 15, 2017 07:07AM H.C. Wainwright Starts Achaogen (AKAO) at Buy

Jun 6, 2017 07:56AM Akebia Therapeutics (AKBA): Another Patent Win - HC Wainwright

May 25, 2017 08:45AM The Life Sciences Report Interviews H.C. Wainwright Analyst Ed Arce

May 23, 2017 07:18AM H.C. Wainwright Assumes Dicerna Pharmaceuticals (DRNA) at Buy

May 18, 2017 07:19AM Aurinia Pharmaceuticals (AUPH): Cutting PT On Dilution - HC Wainwright

May 16, 2017 07:26AM Akebia Therapeutics (AKBA): Raising PT On Key Contract - HC Wainwright

Apr 27, 2017 07:43AM Akebia Therapeutics (AKBA): European Partnership Removes Funding Concerns - HC Wainwright

Apr 17, 2017 07:23AM Cidara Therapeutics (CDTX) PT Lowered to $14 at H.C. Wainwright on Higher 2017 Operating Expenses

Apr 11, 2017 07:13AM Paratek Pharmaceuticals (PRTK): Blockbuster Becoming More Likely - HC Wainwright

Mar 30, 2017 07:28AM CymaBay Therapeutics (CBAY): Positive on the Appointment of Sujal Shah as Interim CEO - HC Wainwright

Mar 30, 2017 07:06AM H.C. Wainwright Upgrades Galectin Therapeutics (GALT) to Buy, Major Catalyst in Dec.

Mar 27, 2017 07:20AM Galmed Pharma (GLMD): Cutting PT On Dilution - HC Wainwright

Mar 27, 2017 07:11AM CymaBay Therapeutic (CBAY) PT Raised to $7 at H.C. Wainwright; 'Transformational Year Ahead for Seladelpa'

Mar 20, 2017 07:28AM Medicines Co. (MDCO): Cardiologist Survey Reveals Positive Outlook Despite Headline FOURIER Results - HC Wainwright

Mar 16, 2017 07:37AM Conatus Pharmaceuticals (CNAT): Novartis License Option for Emricasan Likely in 2Q - HC Wainwright

Mar 15, 2017 08:19AM Ocera Therapeutics (OCRX): Major Catalyst Coming in 3Q - HC Wainwright

Mar 15, 2017 07:56AM DURECT Corp (DRRX): Clinical Data of DUR-928 Expected Next Month - HC Wainwright

Mar 3, 2017 07:10AM Aurinia Pharmaceuticals (AUPH) PT Raised to $12 at H.C. Wainwright Following Recent Positive Data

Feb 28, 2017 07:11AM H.C. Wainwright Starts Durect Corp (DRRX) at Buy

Feb 27, 2017 07:52AM Medicines Co. (MDCO): Raising PT On Document Analysis - HC Wainwright

View More Recent Stories View Older Stories